Revenue Breakdown
Composition ()
No data
Revenue Streams
PMGC Holdings Inc (ELAB) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Enfinity, accounting for 66.7% of total sales, equivalent to $404.15K. Another important revenue stream is Empower. Understanding this composition is critical for investors evaluating how ELAB navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Evaluating the bottom line, PMGC Holdings Inc maintains a gross margin of 14.95%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -767.53%, while the net margin is -914.86%. These profitability ratios, combined with a Return on Equity (ROE) of -76.20%, provide a clear picture of how effectively ELAB converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ELAB competes directly with industry leaders such as AQB and HCWB. With a market capitalization of $4.21M, it holds a leading position in the sector. When comparing efficiency, ELAB's gross margin of 14.95% stands against AQB's N/A and HCWB's 20.00%. Such benchmarking helps identify whether PMGC Holdings Inc is trading at a premium or discount relative to its financial performance.
